Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
1951 births
acute myeloid leukemia
american cardiologists
american society of clinical oncology
applied therapeutics
biosimilars
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
cancer
cell therapy
christopher heery
cincor pharma
clinical trials
coronavirus
covid-19
cystic fibrosis
deals
detroit blog main
detroit top stories
diabetic cardiomyopathy
drug prices
drugs
duchenne muscular dystrophy
duke university alumni
duke university faculty
elevatebio
eqt partners
fda
federal trade commission
fentanyl
food and drug administration
gene therapy
generic drugs
ginkgo bioworks
hepatitis c
human microbiome
What
commissioner
3
×
fda
3
×
actually
ahead
asco
believes
best
bio
branded
califf
chief
choices
cold
consumers
coronavirus
costly
counterweight
diagnosis
drugs
early
elevatebio
engagement
experiencing
following
foster
generic
gottlieb
graft
innovation
medications
medicine
mild
positive
president
regulation
regulations
reports
right
rises
robert
Language
unset
Current search:
fda
×
commissioner
×
@bgr.com
3 years ago
Former FDA chief says this is the best coronavirus medicine Trump can get right now
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@WIRED
7 years ago
FDA commissioner Robert Califf believes smart regulations can actually foster innovation.